You are here: Home » Companies » News
Dubai-based Coral Energy turns focus to Asia, halts trade in Russian crude
Business Standard

Orchid Pharma antibiotic product for treating UTI coming to India: MD

Company says it's returning to profit after takeover by Dhanuka Laboratories under insolvency resolution

Topics
Orchid Pharma | Pharma sector | UTI

Sohini Das  |  Mumbai 



pharma
Enmetazobactam, in combination with cefepime, addresses the need to tackle bacteria developing resistance against antibiotics

Orchid Pharma, which was taken over by Dhanuka Laboratories under insolvency resolution in March 2020, is making a turn-around in revenue and profit as it commercialises a molecule developed in-house, said its senior executive.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

Insightful news, sharp views, newsletters, e-paper, and more! Unlock incisive commentary only on Business Standard.

Download the Business Standard App for latest Business News and Market News .

First Published: Thu, November 24 2022. 14:04 IST

RECOMMENDED FOR YOU

.